Evidence map›Paper›PMID 31966622›Full record

ArticleInternational journal of clinical and experimental pathology2017

MicroRNA-140 inhibits tumor progression in nasopharyngeal carcinoma by targeting CXCR4.

Chengyun Yao, Shengfu Huang, Jianfeng Wu, Li Yin, Xuesong Jiang, Cheng Chen, Wenlan Wu, Jianhua Xu, Xia He

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chengyun YaoDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Shengfu HuangDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Jianfeng WuDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Li YinDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Xuesong JiangDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Cheng ChenDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Wenlan WuHead and Neck Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Jianhua XuDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Xia HeDepartment of Radiotherapy, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital Nanjing 210009, China.
Jiangsu Cancer Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence has indicated that miRNAs play important roles in carcinogenesis. The identification of dysregulated miRNAs and the target genes they regulate might enhance our understanding of the molecular mechanisms of nasopharyngeal carcinoma (NPC). microRNA-140 (miR-140) has been found to be down-regulated in cancer. However its role in nasopharyngeal carcinoma remains unclear. CXCR4 was predicted to be the target gene of miR-140. The current research was designed to delineate the mechanism of miR-140 in regulating NPC via targeting CXCR4. In this study, miR-140 was underexpressed in NPC tissues and cell lines compared with their normal controls and the biological function and direct target genes of miR-140 in NPC cells were investigated. Importantly, we demonstrate that the over expression of miR-140 significantly inhibits NPC cell proliferation and induces apoptosis. Additionally, CXCR4 was predicted the target gene of miR-140 and the luciferase reporter assay revealed that miR-140 was directly bound to the 3'-UTR of CXCR4. Furthermore, CXCR4 was inversely correlated with the expression of miR-140 in NPC cells. Taken together, our results suggest miR-140 suppresses tumor proliferation and induces apoptosis by inhibiting CXCR4, which might provide a new insight into the molecular mechanisms that regulate the development and progression of NPC, and it provides novel therapeutic targets for NPC.

Indexed as

apoptosisCXCR4miR-140Nasopharyngeal carcinomaproliferation

Identifiers

PMID31966622
PMCPMC6965283
OpenAlexW3028382749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.